These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8214294)

  • 1. Differential oncogenic expression in thyroid follicular and Hürthle cell carcinomas.
    Masood S; Auguste LJ; Westerband A; Belluco C; Valderama E; Attie J
    Am J Surg; 1993 Oct; 166(4):366-8. PubMed ID: 8214294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues.
    Mizukami Y; Nonomura A; Yamada T; Kurumaya H; Hayashi M; Koyasaki N; Taniya T; Noguchi M; Nakamura S; Matsubara F
    Anticancer Res; 1990; 10(5A):1115-26. PubMed ID: 1978632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid.
    Segev DL; Saji M; Phillips GS; Westra WH; Takiyama Y; Piantadosi S; Smallridge RC; Nishiyama RH; Udelsman R; Zeiger MA
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2036-42. PubMed ID: 9626136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
    Sugishita Y; Kammori M; Yamada O; Yamazaki K; Ito K; Fukumori T; Yoshikawa K; Yamada T
    Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor markers and oncogene expression in thyroid cancer using biochemical and immunohistochemical studies.
    Hashimoto T; Matsubara F; Mizukami Y; Miyazaki I; Michigishi T; Yanaihara N
    Endocrinol Jpn; 1990 Apr; 37(2):247-54. PubMed ID: 1699752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid follicular oncogenesis in iodine-deficient and iodine-sufficient areas: search for alterations of the ras, met and bFGF oncogenes and of the Rb anti-oncogene.
    Bartolone L; Vermiglio F; Finocchiaro MD; Violi MA; French D; Pontecorvi A; Trimarchi F; Benvenga S
    J Endocrinol Invest; 1998 Nov; 21(10):680-7. PubMed ID: 9854684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of Hurthle cell neoplasms by gene profiling.
    Finley DJ; Zhu B; Fahey TJ
    Surgery; 2004 Dec; 136(6):1160-8. PubMed ID: 15657571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta type II receptors and smad proteins in follicular thyroid tumors.
    West J; Munoz-Antonia T; Johnson JG; Klotch D; Muro-Cacho CA
    Laryngoscope; 2000 Aug; 110(8):1323-7. PubMed ID: 10942134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
    Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
    Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expressions of fatty acid synthase and phosphorylated c-Met in thyroid carcinomas of follicular origin.
    Liu J; Brown RE
    Int J Clin Exp Pathol; 2011; 4(8):755-64. PubMed ID: 22135723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
    Nikiforova MN; Lynch RA; Biddinger PW; Alexander EK; Dorn GW; Tallini G; Kroll TG; Nikiforov YE
    J Clin Endocrinol Metab; 2003 May; 88(5):2318-26. PubMed ID: 12727991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
    Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
    BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene expression in follicular neoplasms of the thyroid.
    Auguste LJ; Masood S; Westerband A; Belluco C; Valderamma E; Attie J
    Am J Surg; 1992 Dec; 164(6):592-3. PubMed ID: 1361106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RET receptor expression in thyroid follicular epithelial cell-derived tumors.
    Bunone G; Uggeri M; Mondellini P; Pierotti MA; Bongarzone I
    Cancer Res; 2000 Jun; 60(11):2845-9. PubMed ID: 10850426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
    Cheung L; Messina M; Gill A; Clarkson A; Learoyd D; Delbridge L; Wentworth J; Philips J; Clifton-Bligh R; Robinson BG
    J Clin Endocrinol Metab; 2003 Jan; 88(1):354-7. PubMed ID: 12519876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
    Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
    Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
    Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumors: an immunohistochemical study.
    Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
    Anticancer Res; 1995; 15(3):755-9. PubMed ID: 7645954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
    Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.